Goal: A focused clinical hyperthermia (HT) system is presented for treatment of locally advanced breast cancer. Methods: The system consists of water-cooled phased array (PA) applicator integrated in treatment bed controlled by a programmable 434 MHz microwave source and patient-specific HT treatment planning (HTP) system with fiber-optic thermometry and user interface for system control and monitoring. Results: PA applicator performance in patient-derived breast models and experiments in layered cylindrical phantom with HTP demonstrate the ability to deliver focused heating with low active reflection coefficients and channel power consumption. Conclusions: Thermal regulation and low cross coupling between PA elements significantly reduced the power consumption for focused HT, confirming that the proposed system is affordable and rugged for clinical adoption.
No takes yet. Share an insight, caveat, or question.
Choudhary et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: